Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998:75:135-61.
doi: 10.1016/s0065-230x(08)60741-1.

Differentiation and cancer in the mammary gland: shedding light on an old dichotomy

Affiliations
Review

Differentiation and cancer in the mammary gland: shedding light on an old dichotomy

O W Petersen et al. Adv Cancer Res. 1998.

Abstract

In this brief review, the development of breast cancer is discussed from the vantage of phenotypic differentiation, similar to what has been considered over the years for leukemias and melanomas, both of which express easily visible differentiation markers (Hart and Easty, 1991; Clarke et al., 1995; Lynch, 1995; Sachs, 1996; Sledge, 1996). The review is divided into a theoretical background for human breast differentiation and a discussion of recent experimental results in our laboratories with differentiation of breast epithelial cells. In the theoretical background, in situ markers of differentiation of normal breast and carcinomas are discussed with emphasis on their possible implications for tumor therapy. So far, most of the emphasis regarding differentiation therapy of tumors has been focused on the possible action of soluble factors, such as colony-stimulating factors in leukemias and retinoic acids in solid tumors (Lotan, 1996; Sachs, 1996). However, an emerging and promising new avenue in this area appears to point to additional factors, such as the cellular form and extracellular matrix (ECM) (Bissel et al., 1982; Bissel and Barcellos-Hoff, 1987; Ingber, 1992). The recent interest in these parameters has evolved along with an increasing understanding of the molecular composition of the ECM, and of the molecular basis of the classical findings that normal cell--in contrast to tumor cells--are anchorage dependent for survival and growth (Folkman and Moscona, 1978; Hannigan et al., 1996). We now know that this is the case for epithelial as well as fibroblastic cells, and that interaction with ECM is crucial for such regulation. Indeed, ECM and integrins are emerging as the central regulators of differentiation, apoptosis, and cancer (Boudreau et al., 1995; Boudreau and Bissel, 1996; Werb et al., 1996; Bissell, 1997; Weaver, et al., 1997). In the experimental part, we elaborate on our own recent experiments with functional culture models of the human breast, with particular emphasis on how "normal" and cancer cells could be defined within a reconstituted ECM. Special attention is given to integrins, the prominent ECM receptors. We further discuss a number of recent experimental results, all of which point to the same conclusion: namely that phenotypic reversion toward a more normal state for epithelial tumors is no longer an elusive goal. Thus "therapy by differentiation" could be broadened to include not only blood-borne tumors, but also solid tumors of epithelial origin.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Diagram illustrating the normal phenotype of a cell in a triangle between growth, death, and differentiation. The extracellular matrix (ECM) is proposed to play an important role via integrin-mediated signaling.
Fig. 2
Fig. 2
Morphological characterization of the HMT-3522 series in the EHS assay. Phase-contrast micrographs of S1 cells (A), S2 cells (B), and T4-2 cells (C) plated inside EHS and cultured for 12 days in serum-free conditions. Whereas the “normal” S1 cells form typical acinus-like spheres, a subpopulation of the “benign” S2 cells form megaclusters reminiscent of hyperplasia, and the T4-2 cells form smaller irregular colonies with some penetration of cells into the EHS, similar to invasion (arrowhead in C). Magnification, ×90. Bar = 100 µm.
Fig. 3
Fig. 3
Characterization of basement membrane deposition of the HMT-3522 series. Light micrographs of cryostat sections of S1 cells (A), S2 cells (B), and T4-2 cells (C) immunoperoxidase stained for human type IV collagen and counterstained with hematoxylin. Note that although the S1 cells deposit an almost continuous basement membrane, this is lost in the S2 cells. The T4-2 cells deposited a disorganized and apolar basement membrane. Magnification, ×150. Bar = 100 µm.
Fig. 4
Fig. 4
β1-Inhibitory antibody treatment of tumor cells leads to the formation of reverted acini. (A–A″) Confocal fluoresence microscopy images of F-actin. Both the S1 (A) and T4-β1 reverted acini (A″) showed basally localized nuclei (propidium iodide) and organized filamentous F-actin (FITC), whereas T4-2 mock-treated colonies (T4-2 IgG) had disorganized, hatched bundles of actin and pleiomorphic nuclei (A′). (B–B″) Confocal immunofluorescence microscopy images of E–cadherin (FITC) and β-catenin (Texas red): In S1 (B) and T4-β1 reverted acini (B″), E-cadherin and β-catenins were colocalized and superimposed at the cell–cell junctions. Reproduced from Weaver et al., (1997). J. Cell Biol. 137, 231–245, by permission of The Rockefeller University Press.

Similar articles

Cited by

References

    1. Adams JC, Watt FM. Development. 1993;117:1183–1198. - PubMed
    1. Aggeler J, Ward J, Blackie L, Barcellos-Hoff MH, Streuli CH, Bissell MJ. J. Cell Biol. 1991;99:407–477. - PubMed
    1. Albrechtsen R, Nielsen M, Wewer U, Engvall E, Ruoslahti E. Cancer Res. 1981;41:5076–5081. - PubMed
    1. Bani D, Riva A, Bigazzi M, Sacchi BT. Br. J. Cancer. 1994;70:900–904. - PMC - PubMed
    1. Barbareschi M, Caffo O, Doglioni C, Fina P, Marchetti A, Buttitta F, Leek R, Morelli L, Leonardi E, Bevilacqua G, Dalla Palma P, Harris AL. Br. J. Cancer. 1996;74:208–215. - PMC - PubMed

Publication types